{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:51:12Z","timestamp":1791093072486,"version":"4.1.0"},"reference-count":58,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T00:00:00Z","timestamp":1393200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Anti\u2010inflammation strategy is one of the proposed therapeutic approaches to hepatic fibrosis. <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content> helper (<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>h) 17 cells, which play a detrimental role in experimental murine models of inflammatory diseases, have been demonstrated to participate in the pathogenesis of liver damage. The inhibitory effect of halofuginone (<jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>), an active component of extracts derived from the plant alkaloid febrifugine, on collagen synthesis has been shown in animal models of the fibrotic disease. The aim of this study was to clarify the <jats:italic>in vivo<\/jats:italic> effect of <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content> on <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>h17 cells in concanavalin <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\u2010induced fibrosis rats. <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>aematoxylin\u2013eosin (<jats:styled-content style=\"fixed-case\">HE<\/jats:styled-content>) staining and Masson staining were performed to observe collagen deposition. The presence of <jats:styled-content style=\"fixed-case\">INF<\/jats:styled-content>\u2010gamma, <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010alpha, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20101beta, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201033 and <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201010 in serum and the presence of <jats:styled-content style=\"fixed-case\">ROR<\/jats:styled-content>\u2010<jats:italic>\u03b3<\/jats:italic>t, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017, <jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010<jats:italic>\u03b2<\/jats:italic>1 and <jats:italic>\u03b1<\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content> in liver tissue were detected. Flow cytometry was performed to analyse the percentage of Th17 cells. We observed significantly lower levels of <jats:styled-content style=\"fixed-case\">INF<\/jats:styled-content>\u2010gamma, <jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010alpha, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20106, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u201017, <jats:styled-content style=\"fixed-case\">IL<\/jats:styled-content>\u20101beta, <jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010<jats:italic>\u03b2<\/jats:italic>1 and <jats:italic>\u03b1<\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">SMA<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\u2010treated group of rats, and the percentage of Th17 cells in splenic lymphocyte was decreased well. Histological examination demonstrated that <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content> significantly reduced the severity of liver fibrosis in <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content>\u2010treated rats. We concluded that <jats:styled-content style=\"fixed-case\">HF<\/jats:styled-content> (10\u00a0mg\/kg) exerts an antifibrotic impact on Th17 cells and its relative cytokines in rats with ConA\u2010induced fibrosis.<\/jats:p>","DOI":"10.1111\/sji.12144","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T18:32:41Z","timestamp":1388687561000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Effect of Antifibrotic Drug Halofugine on Th17 Cells in Concanavalin A\u2010Induced Liver Fibrosis"],"prefix":"10.1111","volume":"79","author":[{"given":"J.","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.\u2010W.","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of anatomy Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010B.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiology Affiliated Hospital of Qingdao University School of Medicine Qingdao University China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u2010H.","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.\u2010Y.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Immunology Medical College of Qingdao University QingDao China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00414.2010"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.042"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04658.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24282"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095906"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900408106"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04471.x"},{"key":"e_1_2_7_10_1","first-page":"345803","article-title":"Role of IL\u201017 and Th17 cells in liver diseases","volume":"2011","author":"Hammerich L","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23273"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.031"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017484"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22680"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.12.5483"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.150.12.5445"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.5"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900043"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2008.03.015"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21408"},{"key":"e_1_2_7_22_1","first-page":"30","article-title":"Halofuginone reduces the occurrence of renal fibrosis in 5\/6 nephrectomized rats","volume":"9","author":"Benchetrit S","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00151-4"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000091262.01493.e3"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000176551.09051.f2"},{"key":"e_1_2_7_26_1","first-page":"479","article-title":"Halofuginone down\u2010regulates Smad3 expression and inhibits the TGFbeta\u2010induced expression of fibrotic markers in human corneal fibroblasts","volume":"18","author":"Nelson EF","year":"2012","journal-title":"Mol Vis"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2010.05.004"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115836"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.32.1215"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033577"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200213"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.04.044"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208544200"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120619"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.035"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007347"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.09.014"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2004.12.015"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1996.0075"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.018"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1539"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026713"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0705409"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0292com"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00164-2"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1172638"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.29.1651"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2010.00428.x"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.018"},{"key":"e_1_2_7_50_1","first-page":"385","article-title":"IL\u201017 expression is correlated with hepatitis B\u2010related liver diseases and fibrosis","volume":"27","author":"Wang L","year":"2011","journal-title":"Int J Mol Med"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039307"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103801"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2003.00074.x"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2007.10.011"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.01885.x"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.01.001"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2277"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(05)70168-9"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fsji.12144","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/sji.12144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T11:23:34Z","timestamp":1695986614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/sji.12144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1111\/sji.12144"],"URL":"https:\/\/doi.org\/10.1111\/sji.12144","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]},"assertion":[{"value":"2013-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-02-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}